OSL oncosil medical ltd

Ann: Appendix 4E Preliminary Financial Report, page-3

  1. 5 Posts.
    Revenues down 12.7%
    Consulting, finance and legal costs up $1m
    Net foreign exchange loss of $0.25m
    APAC and NZ gone.

    We're basically in September so Oncosil must have about $2.5m in cash at their current burn rate? Does that mean they are at risk of being delisted?

    Interestingly, APAC has a revenue of $15k... my guess is that is roughly what a single dose costs.

    Not looking good fellas.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
96.0¢
Change
0.010(1.05%)
Mkt cap ! $13.65M
Open High Low Value Volume
$1.00 $1.03 96.0¢ $12.69K 13.20K

Buyers (Bids)

No. Vol. Price($)
2 1185 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.05 1000 1
View Market Depth
Last trade - 10.30am 18/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.